Shares of Healthequity Inc (NASDAQ:HQY) have been assigned a consensus recommendation of “Buy” from the twelve research firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $57.50.
HQY has been the subject of a number of research reports. BidaskClub cut shares of Healthequity from a “hold” rating to a “sell” rating in a report on Thursday, December 7th. JPMorgan Chase & Co. reduced their target price on shares of Healthequity from $52.00 to $51.00 and set an “overweight” rating for the company in a report on Wednesday, January 24th. Zacks Investment Research cut shares of Healthequity from a “buy” rating to a “hold” rating in a report on Wednesday, November 15th. Chardan Capital upped their target price on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a report on Wednesday, December 6th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 target price on shares of Healthequity in a report on Tuesday, December 5th.
In other news, VP Darcy G. Mott sold 9,500 shares of the business’s stock in a transaction dated Wednesday, December 20th. The shares were sold at an average price of $47.91, for a total transaction of $455,145.00. Following the transaction, the vice president now directly owns 96,500 shares in the company, valued at $4,623,315. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Jon Kessler sold 40,000 shares of the business’s stock in a transaction dated Thursday, January 25th. The stock was sold at an average price of $49.47, for a total transaction of $1,978,800.00. Following the transaction, the insider now owns 485,000 shares in the company, valued at $23,992,950. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 661,732 shares of company stock worth $34,493,276. Company insiders own 19.00% of the company’s stock.
Shares of Healthequity (HQY) opened at $58.87 on Wednesday. Healthequity has a 1-year low of $37.62 and a 1-year high of $59.99. The company has a market cap of $3,590.60, a PE ratio of 84.54, a PEG ratio of 2.26 and a beta of 1.46.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.